Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Rapid correction of low vitamin D status in nursing home residents 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. Medicare pay-for-reporting effort draws fire from frustrated doctors 5. Allopurinol-induced recurrent dress syndrome: Pathophysiology and treatment
Top Ten Searches
rheumatoid arthritis lupus polymyalgia sjogrens fibromyalgia amyloidosis vasculitis urate raynauds myositisYour Article Summary
The relationship between inflammation and new bone formation in patients with ankylosing spondylitis
Arthritis Research & Therapy, 09/05/08
Baraliakos X et al. – In patients with ankylosing spondylitis (AS), treated with anti-TNF agents, linkage and some dissociation of inflammation and new bone formation was found. More effective suppression of spinal inflammation may be required to inhibit structural damage in ankylosing spondylitis.
Methods- Study to investigate whether and how spinal inflammation is associated with new bone formation in AS
- Spinal MRI and conventional radiographs from 39 AS pts treated with anti-TNF agents at baseline and after 2 yrs were analysed
- 922 vertebral edges at the cervical and lumbar spine were analysed
- At baseline, the proportion of vertebral edges with and w/o inflammation that showed structural changes was similar
- From the perspective of syndesmophyte formation after 2 yrs, there were more vertebral edges w/o than with inflammation at baseline
- From the perspective of spinal inflammation at baseline more syndesmophytes developed at vertebral edges with than w/o inflammation
- Inflammation persisted in 31% of the initially inflamed vertebral edges, and new lesions developed in 8% of the vertebral edges w/o inflammation at baseline
- From the perspective of spinal inflammation after 2 yrs, 5.6% of the vertebral edges showed syndesmophyte development, vs 1.9% of the vertebral edges with new syndesmophytes w/o inflammation
Related Articles
Evaluation of inflammation and oxidative stress in ankylosing spondylitis: a role for macrophage migration inhibitory factor
Modern Rheumatology, 10/05/09
Relevance Score: 45%
Use of a Percutaneous Diskectomy Device to Facilitate the Diagnosis of Infectious Spondylitis
American Journal of Neuroradiology, 11/13/09
Relevance Score: 43%
Erythrocyte sedimentation rate, CRP level, and serum amyloid a protein for patient selection and monitoring of anti-tumor necrosis factor treatment in ankylosing spondylitis
Arthritis Care and Research, 11/02/09
Relevance Score: 43%
A 2-year comparative open label randomized study of efficacy and safety of etanercept and infliximab in patients with ankylosing spondylitis
Rheumatology International, 10/27/09
Relevance Score: 43%
Recent studies on the genetic basis of ankylosing spondylitis
Current Rheumatology Reports, 10/09/09
Relevance Score: 43%
Today in Basic Science/Genetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Mutations in the perforin gene can be linked to macrophage activation syndrome in patients with systemic onset juvenile idiopathic arthritis
Rheumatology, 12/20/09
The 'RASor's' edge: Ras proteins and matrix destruction in arthritis
Arthritis Research & Therapy, 12/19/09
Unresponsiveness to colchicine therapy in patients with familial Mediterranean fever homozygous for the M694V mutation
Journal of Rheumatology, 12/17/09
Today in Spondylarthropathies...keeping you current
Receive free subspecialty "5-minute updates" via email
The effect of anti-TNF agent on oxidation status in patients with ankylosing spondylitis
Clinical Rheumatology, 12/17/09
Programmed cell death 1 gene polymorphisms is associated with ankylosing spondylitis in Chinese Han population
Rheumatology International, 12/16/09
Human leukocyte antigen-G in ankylosing spondylitis and the response after tumour necrosis factor-&alpha blocker therapy
Rheumatology, 12/15/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


